BIOTECH

BIOTECH

RheumaGen, Inc. Launches with $15 Million Series A Financing to Advance a New Class of HLA Gene-Editing Therapies for Major Autoimmune Diseases

Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401,...

Read more

BIOTECH

Cilcare completes a €40M series A

The funds will support two Phase 2a clinical trials for the drug candidate CIL001, targeting...

Read more

BIOTECH

Doron Therapeutics Raises $11M Series A to Progress Biologic Regenerative Osteoarthritis Drug into Phase 3 Clinical Studies

CHAPEL HILL, NC / ACCESSWIRE / November 25, 2024 / Doron Therapeutics, a clinical-stage biotech company...

Read more

BIOTECH

Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year – Europe”

Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar’s novel oral plant-based...

Read more

BIOTECH

ObvioHealth Welcomes Richard Watkins as Chief Revenue Officer at a Pivotal Moment of Transformation

Experienced Sales Leader to Drive Revenue Growth as ObvioHealth Transitions to Enterprise Solutions NEW YORK, Oct....

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.